Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Izzy who wrote (4195)	5/4/1998 2:26:00 PM
From: Steve Fancy	Read Replies (1) \| Respond to of 6136

Isaac, the ENMD developments are a potential miracle from the little bit I know. I have no idea if their drug is expected to treat the same types of cancer as AGPH's or others, in fact I know almost nothing about it, but seems to me that it could potentially take the wind out of competitors sails. Could also draw more attention. We'll have to see. I have thought about calling IR, but I don't think I want to hear the answer right now. My experience with IR departments in general is they answer the question without answering the question...just get 'em to go away. If we don't hear something further in the next week and a half, I will call in order to make decisions before May expiration. regards, sf